Hasil Pencarian (1)
small molecule | CAS: 302962-49-8
Dasatinib is an orally available multikinase inhibitor indicated for the treatment of Philadelphia chromosome (Ph)-positive leukemias.[A2224,L45171] Ph is a chromosomal abnormality found in patients with chronic myelogenous leukemia (CML) and acute lymphocyti…
Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBcr-Abl Tyrosine Kinase Inhibitors
+31
Target Protein:
Tyrosine-protein kinase ABL1Proto-oncogene tyrosine-protein kinase SrcEphrin type-A receptor 2
+20
Waktu ParuhThe terminal half-l…
Vol. DistribusiDasatinib has an ap…
KlirensThe clearance of da…
Genetik
-